OPCH director buys 38,000 shares at $25.984 avg on Nov 3, 2025

Option Care Health (OPCH) reported an insider purchase by a director.

Accepted by SEC EDGAR 11/04/2025 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Option Care Health (OPCH) reported an insider purchase by a director. On November 3, 2025, the reporting person bought 38,000 shares of common stock at a weighted average price of $25.984 per share, executed across multiple trades priced between $25.835 and $26.235.

Following this transaction, the director beneficially owned 413,390 shares, held directly. The filing notes the weighted average and offers to provide detailed trade-by-trade pricing upon request.

Insider Trade Summary

Net Buyer: 38,000 shares

Net Buy 1 txn

Insider KRAEMER HARRY M JANSEN JR

Role Director

Bought 38,000 shs ($987K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	38,000	$25.984	$987K

Holdings After Transaction: Common Stock — 413,390 shares (Direct)

Footnotes (1)

1. F1. Reflects the weighted average price of 38,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on November 3, 2025 with purchase prices ranging from $25.835 to $26.235 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who reported a transaction in OPCH and what is their role?

A director of Option Care Health reported the transaction on a Form 4.

How many OPCH shares were purchased and on what date?

The director purchased 38,000 shares on November 3, 2025.

What was the average price paid for the OPCH shares?

The weighted average price was $25.984 per share.

What was the price range of the individual trades?

Trades were executed between $25.835 and $26.235 per share.

How many OPCH shares does the reporting person own after the purchase?

After the transaction, the reporting person beneficially owned 413,390 shares.

Is the ownership classified as direct or indirect?

The filing lists the ownership as Direct (D).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KRAEMER HARRY M JANSEN JR

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/03/2025		P		38,000	A	$25.984(1)	413,390	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the weighted average price of 38,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on November 3, 2025 with purchase prices ranging from $25.835 to $26.235 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

	/s/ Michael Bavaro, attorney-in-fact for Mr. Kraemer	11/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.